Article
Expression profiles of nintedanib-targeting molecules in progressive fibrotic interstitial lung diseases (non-IPF-PF) and IPF
2023-07-20
Abstract excerpt
<h4>Background: </h4> Idiopathic pulmonary fibrosis (IPF) and other types of progressive fibrotic interstitial lung diseases (non-IPF-PF), such as chronic hypersensitivity pneumonitis (cHP), systemic sclerosis (SSc), non-specific interstitial pneumonia (NSIP), and sarcoidosis, are common interstitial lung diseases. Nintedanib is one of the two approved therapies that can significantly slow the progression of IPF....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fc63fe5d-9ed7-5019-aca6-1d5242b79401
- DOI
- 10.21203/rs.3.rs-3171136/v1
